Cognition Therapeutics, Inc. Profile Avatar - Palmy Investing

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead…

Biotechnology
US, Purchase [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Cognition Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Cognition Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Cognition Therapeutics, Inc..

End of CGTX's Analysis
CIK: 1455365 CUSIP: 19243B102 ISIN: US19243B1026 LEI: - UEI: -
Secondary Listings
CGTX has no secondary listings inside our databases.